New treatment options for chronic constipation: mechanisms, efficacy and safety. - Wikidata - awgldk - TriplyDB

New treatment options for chronic constipation: mechanisms, efficacy and safety.

New treatment options for chronic constipation: mechanisms, efficacy and safety.

http://www.wikidata.org/entity/Q37960501

about

Mechanisms of Electrical Activation and Conduction in the Gastrointestinal System: Lessons from Cardiac Electrophysiology Efficacy and Safety of Prucalopride in Chronic Constipation: An Integrated Analysis of Six Randomized, Controlled Clinical Trials.

P2860

Q26746023-FBC957DC-B2BB-4D5E-B988-E72983EE3543 Q37092661-44E62C54-8FC6-46A3-9338-C2690B7E53D1

P2860

New treatment options for chronic constipation: mechanisms, efficacy and safety.

http://www.wikidata.org/entity/Q37960501

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

New treatment options for chronic constipation: mechanisms, efficacy and safety.

@en

New treatment options for chronic constipation: mechanisms, efficacy and safety.

@nl

type

label

New treatment options for chronic constipation: mechanisms, efficacy and safety.

@en

New treatment options for chronic constipation: mechanisms, efficacy and safety.

@nl

prefLabel

New treatment options for chronic constipation: mechanisms, efficacy and safety.

@en

New treatment options for chronic constipation: mechanisms, efficacy and safety.

@nl

P1433

Q37960501-A54BE735-6FA2-4705-A30A-A16B2DBBBF59

P1476

Q37960501-1D65A6C5-7536-4F95-8969-83302F228423

P2860

Q37960501-001814EF-A53E-4BEC-9B0C-2C212882E91E

Q37960501-0996DA47-D2BA-4EC3-9335-2E83E6DFBF53

Q37960501-0A137FD4-3A85-4B16-9FE6-57141995E314

Q37960501-14EEFD27-6F1E-409D-95D4-D7366DC30C15

Q37960501-16237F9A-4075-42D1-B60A-BF3B723B68AC

Q37960501-165FDE0D-9332-41E1-BD4F-6401C8B125E3

Q37960501-1B2F63E0-6AA7-4C60-AFB7-34BA2A7CB397

Q37960501-1C0DC53B-0BBA-4058-9979-CE60AAD99E00

Q37960501-1D5990A5-3F2B-42F5-BEB2-F6802331C619

Q37960501-1F149CDD-AE8E-40D5-A702-D74BAC076319

P304

Q37960501-DDC5DBE2-093F-4C68-810F-10134A9519F8

P31

Q37960501-D5C17C45-9D6E-452F-B86D-BC90FC6C7E4A

P356

Q37960501-EC55F95E-8391-4CA1-8A6D-320453DA0E65

P407

Q37960501-0F2234C1-F259-486C-97A0-47AAED6F5C3C

P478

Q37960501-1EC6741A-60D0-40A2-ACB8-8C76DA91B6A3

P50

Q37960501-78D96F09-0625-44E4-BE78-F6BD2A66A7BD

P577

Q37960501-9E4AA4A9-34D0-4885-B259-19B304DDF739

P698

Q37960501-DD105C74-D455-4980-B6F5-A55B9CA13198

P932

Q37960501-B58863DD-CB89-4D48-A0CA-8FF630A1D235

P356

P1433

Canadian Journal of Gastroenterology & Hepatology

P1476

New treatment options for chronic constipation: mechanisms, efficacy and safety.

@en

P2860

Tegaserod for the treatment of irritable bowel syndrome and chronic constipation

Colonic secretion of water and electrolytes induced by bile acids: perfusion studies in man

Effects of Velusetrag (TD-5108) on gastrointestinal transit and bowel function in health and pharmacokinetics in health and constipation

Chenodeoxycholate in females with irritable bowel syndrome-constipation: a pharmacodynamic and pharmacogenetic analysis

Effects of chenodeoxycholate and a bile acid sequestrant, colesevelam, on intestinal transit and bowel function

The 5-HT4 receptor agonist, tegaserod, is a potent 5-HT2B receptor antagonist in vitro and in vivo

The continuing importance of bile acids in liver and intestinal disease

Molecular, pharmacological and functional diversity of 5-HT receptors

Effective lipid modification by partial ileal bypass reduced long-term coronary heart disease mortality and morbidity: five-year posttrial follow-up report from the POSCH. Program on the Surgical Control of the Hyperlipidemias

Treatment of constipation with chenodeoxycholic acid

P304

29B-35B

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1155/2011/670484

http://www.w3.org/2001/XMLSchema#string

P407

P478

25 Suppl B

http://www.w3.org/2001/XMLSchema#string

P50

Michael Camilleri

P577

2011-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22114755

http://www.w3.org/2001/XMLSchema#string

P932

3206563

http://www.w3.org/2001/XMLSchema#string